Page 3 - Physical Function News Today

/PRNewswire/ -- UCB, a global biopharmaceutical company, today announced new data on its investigational IL-17A and IL-17F inhibitor, bimekizumab, and its TNF...

Press release content from Globe Newswire. The AP news staff was not involved in its creation.

THE STANDARD By Augustine Oduor | March 13th 2021 at 00:00:00 GMT +0300 Kenyatta University student project leader Fidel Makatia conducts a demonstration during the launch of a prototype ventilator in April last year. [Elvis Ogina, Standard] Only one private university and six public institutions of higher learning have had their Covid-19 research proposals approved by the Government for funding. The National Research Fund (NRF) approved research proposals from Jomo Kenyatta University of Agr...

Press release content from Globe Newswire. The AP news staff was not involved in its creation. Axogen Sponsored REPOSE℠ Study Completes Pilot Phase Analysis Axogen, Inc.February 18, 2021 GMT ALACHUA, Fla., Feb. 18, 2021 (GLOBE NEWSWIRE) -- Axogen, Inc. (NASDAQ: AXGN), a global leader in developing and marketing innovative surgical solutions for damage or transection to peripheral nerves, today announced completion of pilot phase analysis for its REPOSE clinical study.  Analysis of the REPOS...